Patents by Inventor Christopher LaPlaca

Christopher LaPlaca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240353421
    Abstract: In alternative embodiments, provided are immunohistochemistry (IHC) methods for determining and scoring reproducibly the extent of expression of the protein Melanoma Associated Antigen Gene-A4 (MAGE-A4), in a tissue sample. In alternative embodiments, provided are methods for diagnosing, treating or ameliorating or assessing the risk of recurrence for a cancer or a tumor using an IHC method as provided herein. In alternative embodiments, provided are kits comprising components and instructions for practicing methods as provided herein. The present application describes methods for scoring MAGE-A4 expression and utilizing the score as a companion or complementary diagnostic or to treat or ameliorate cancer or a tumor.
    Type: Application
    Filed: January 30, 2024
    Publication date: October 24, 2024
    Inventors: Sneha Latha Koneru, Andrea Marquez, Maria Barbara Guillergan, Kristopher Kersch, Bethany Wynne, Pedro Corona, Alexander Prenta, Christopher Laplaca, Gregoriy Smiyun
  • Publication number: 20170275944
    Abstract: The present disclosure is directed to a window screen system for use with casement, hopper, awning, utility window designs to prevent dirt, debris, and insects from entering into the interior of the unit. The system can be installed on existing window frames to provide screen protection only when the window is open and a screen is needed. As such, a user can have a clear view out of the glass window without the unsightliness, distortion, or solar blockage that a traditional “always visible” screen causes.
    Type: Application
    Filed: March 23, 2017
    Publication date: September 28, 2017
    Inventor: Christopher LaPlaca